首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2556010篇
  免费   207468篇
  国内免费   4590篇
耳鼻咽喉   36632篇
儿科学   78296篇
妇产科学   67067篇
基础医学   361786篇
口腔科学   72795篇
临床医学   231046篇
内科学   506153篇
皮肤病学   52853篇
神经病学   217601篇
特种医学   100952篇
外国民族医学   950篇
外科学   383552篇
综合类   56993篇
现状与发展   1篇
一般理论   1030篇
预防医学   208476篇
眼科学   59030篇
药学   190865篇
  4篇
中国医学   4960篇
肿瘤学   137026篇
  2019年   20603篇
  2018年   30493篇
  2017年   23011篇
  2016年   24872篇
  2015年   28079篇
  2014年   38580篇
  2013年   58704篇
  2012年   82573篇
  2011年   86433篇
  2010年   49406篇
  2009年   46090篇
  2008年   80511篇
  2007年   85719篇
  2006年   85586篇
  2005年   83392篇
  2004年   79881篇
  2003年   76734篇
  2002年   75201篇
  2001年   115509篇
  2000年   119614篇
  1999年   101081篇
  1998年   28512篇
  1997年   26098篇
  1996年   25947篇
  1995年   25074篇
  1994年   23572篇
  1993年   21928篇
  1992年   81022篇
  1991年   77910篇
  1990年   75058篇
  1989年   72190篇
  1988年   67171篇
  1987年   66033篇
  1986年   62533篇
  1985年   59498篇
  1984年   45106篇
  1983年   38402篇
  1982年   23367篇
  1981年   20719篇
  1979年   42089篇
  1978年   29517篇
  1977年   24870篇
  1976年   23253篇
  1975年   24486篇
  1974年   30287篇
  1973年   28706篇
  1972年   26859篇
  1971年   24721篇
  1970年   23296篇
  1969年   21655篇
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
51.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
52.
53.
54.
55.
56.
57.
58.
Acne vulgaris (acne) is a chronic inflammatory disease of the sebaceous gland, characterized by follicular hyperkeratinization, excessive colonization by Propionibacterium acnes (Pacnes) as well as immune reactions and inflammation. Despite an armamentarium of topical treatments available including benzoyl peroxide, retinoids and azelaic acid, topical antibiotics in monotherapies, especially erythromycin and clindamycin, are still used in Europe to treat acne. This intensive use led to antimicrobial‐resistant P. acnes and staphylococci strains becoming one of the main health issues worldwide. This is an update on the current topical acne treatments available in Europe, their mechanism of action, their potential to induce antimicrobial resistance and their clinical efficacy and safety.  相似文献   
59.
60.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号